ArticleMolecular cancer therapeutics2022

Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT-Stromal and Tgfβ-Dependent Mechanisms.

Haocheng Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.